Clinical Trial Update: Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating cytosine arabinoside and mitoxantrone in juvenile myelomonocytic leukemia patients undergoing repeat stem cell transplanta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Myelomonocytic Leukemia

Drugs mentioned

• Cytosine Arabinoside (cytarabine)
• Mitoxantrone (mitoxantrone)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Leukemia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2012-03-02